Antithrombin III and Fibrinogen Degradation Product (Fragment E) in Diabetic Nephropathy.

Journal of Clinical Pathology - United Kingdom
doi 10.1136/jcp.35.6.661
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Stimulation of Fibrinogen Synthesis in Cultured Rat Hepatocytes by Fibrinogen Degradation Product Fragment D.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Fibrinogen Degradation Product Fragment D Induces Endothelial Cell Detachment by Activation of Cell-Mediated Fibrinolysis.

Journal of Clinical Investigation
Medicine
1992English

Cellular Basis of Diabetic Nephropathy: III. In Vitro GLUT1 mRNA Expression and Risk of Diabetic Nephropathy in Type 1 Diabetic Patients

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Analysis of Fibrinogen Degradation Product in Severe Liver Disorders by Immunoblotting.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1987English

Clinical Significance of Antithrombin III With Special Reference to Diabetic Retinopathy

Japanese Journal of Geriatrics
GerontologyGeriatrics
1979English

Angiopoietins and Diabetic Nephropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Autophagy in Diabetic Nephropathy

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Update in Diabetic Nephropathy

International Journal of Diabetes and Metabolism
2005English

Prognosis in Diabetic Nephropathy.

British Medical Journal
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy